Journal
CLINICAL SCIENCE
Volume 130, Issue 9, Pages 733-746Publisher
PORTLAND PRESS LTD
DOI: 10.1042/CS20150711
Keywords
CD4(+) T-cells; DNA methylation; DUSP3; IgA nephropathy; T-cell receptor; TRIM27; VTRNA2-1
Categories
Funding
- European Framework Programme [QLG1-CT-2000-00464]
- Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica [PON-REC ONEV 134/2011]
- Fondo per gli Investimenti della Ricerca di Base [RBAP11B2SX]
- Regione Puglia [BISIMANE project] [H31D08000030007]
- Schena Foundation
Ask authors/readers for more resources
IgAN (IgA nephropathy) is the most common form of primary glomerulonephritis worldwide and has a strong genetic component. In this setting, DNA methylation could also be an important factor influencing this disease. We performed a genome-wide screening for DNA methylation in CD4(+) T-cells from IgAN patients and found three regions aberrantly methylated influencing genes involved in the response and proliferation of CD4(+) T-cells. Two hypomethylated regions codified genes involved in TCR (T-cell receptor) signalling, TRIM27 (tripartite motif-containing 27) and DUSP3 (dual-specificity phosphatase 3), and an hypermethylated region included the VTRNA2-1 (vault RNA 2-1) non-coding RNA, also known as miR-886 precursor. We showed that the aberrant methylation influences the expression of these genes in IgAN patients. Moreover, we demonstrated that the hypermethylation of the miR-886 precursor led to a decreased CD4(+) T-cell proliferation following TCR stimulation and to the overexpression of TGF beta (transforming growth factor beta). Finally, we found a Th1/Th2 imbalance in IgAN patients. The IL (interleukin)-2/IL-5 ratio was notably higher in IgAN patients and clearly indicated a Th1 shift. In conclusion, we identified for the first time some specific DNA regions abnormally methylated in IgAN patients that led to the reduced TCR signal strength of the CD4(+) T-cells and to their anomalous response and activation that could explain the T-helper cell imbalance. The present study reveals new molecular mechanisms underlying the abnormal CD4(+) T-cell response in IgAN patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available